CLINICAL_TRIALS
trial_result
· 2018-01-26
Clinical Trial Update: Apatinib in Combination With Docetaxel for Patients With Advanced NSCLC [Phase 2]
Summary
Phase 2 trial update evaluating apatinib in combination with docetaxel for advanced lung cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zigong No.1 Peoples Hospital | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN